`George Yancopoulos[George.Yancopoulos@regeneron.com]
`From:
`George Yancopoulos[/O=REGENERON/OU=FIRST ADMINISTRATIVE
`GROUP/CN=RECIPIENTS/CN=GEORGE.YANCOPOULOS]
`Sent:
`Tue 2/2/2010 6:32:42 PM (UTC)
`Subject: DME Phase 2 --- ALL TABLES PDF
`VGFT-OD-0706 Week24.pdf
`
`------ Forwarded Message
`From: Yuhwen Soo <Yuhwen.Soo@regeneron.com>
`Date: Tue, 2 Feb 2010 13:20:04 -0500
`To: George Yancopoulos <George.Yancopoulos@regeneron.com>, Peter Powchik <Peter.Powchik@regeneron.com>, Robert Terifay
`<Robert.Terifay@regeneron.com>
`
`Yuhwen
`_______________________________________________________
`Yuhwen Soo, PhD
`Vice President, Biostatistics and Data Management
`Regeneron Pharmaceuticals, Inc.
`
`Corporate Office:
`777 Old Saw Mill River Road
`Tarrytown, NY 10591-6707
`
`New Jersey Office:
`Somerset Corporate Center IV
`400 Somerset Corporate Boulevard, Suite 601
`Bridgewater, NJ 08807
`
`Office: (914) 345-7399
`Mobile: (914) 471-7165
`yuhwen.soo@regeneron.com <mailto:yuhwen.soo@regeneron.com>
`
`------ End of Forwarded Message
`
`Regeneron Pharmaceuticals, Inc. Exhibit 2035 Page 1
`Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. IPR2023-00884
`
`